Search results
Showing results for
Prof Paul Johnson and his Islet Transplant Research Group have been awarded Horizon 2020 Funding as part of the DRIVE Consortium to evaluate and develop novel biomaterials and macroencapsulation strategies for transplanting islets without immunosuppression. This new award adds to their current FP7 European Funding, in which the Group has been evaluating and optimising islet function and survival within the MAILPAN (Deymed) device, with 'first in man' implantation planned in Oxford for 2016.
Faculty development
Faculty development
Clinical course
Clinical course
Patient and public engagement
Information about public and patient engagement with the study
News and publications
Latest news and publications
VANGUARD PATH
VANGUARD PATH homepage
Background
Background
Study aims
Information on the study and its aims
Digital pathology and AI – Advances in techniques and technology
Description of advances in pathology
Oxford Open Grand Rounds
Oxford Open Grand Rounds